Bioavailability and Kinetics of Cibenzoline in Patients with Normal and Impaired Renal Function
Authors:
- 1 January 1991
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 31 (1) , 38-44
Abstract
To test the hypothesis that renal failure alters the disposition of cibenzoline in humans, an absolute bioavailability and elimination kinetic study was performed. We used the simultaneous administration of a stable isotope variant (SASIV). Eight healthy volunteers and eight matched hemodialysis patients each received simultaneously an 80‐mg intravenous infusion of 15N‐2‐cibenzoline and a single 80‐mg cibenzoline capsule. Cibenzoline plasma concentrations were assayed by a gas chromatographic—mass spectrometric assay. A compartment‐independent kinetic analysis showed a plasma clearance of 707 mL/min and an elimination half‐life of 7.3 hours after the intravenous dose in healthy volunteers. In renal‐failure patients, cibenzoline clearance decreased to 224 mL/min and half‐life increased to 22.4 hours. Decreased plasma clearance was due to decreases in both renal and nonrenal clearance. Absolute bioavailability was 83% and 90% in healthy volunteers and renal‐failure patients, respectively. Hemodialysis accounted for only 13% of drug clearance.Keywords
This publication has 13 references indexed in Scilit:
- Estimation of drug absorption rates using a deconvolution method with nonequal sampling timesJournal of Pharmacokinetics and Biopharmaceutics, 1986
- Pharmacokinetics of Cibenzoline in Patients With Renal ImpairmentThe Journal of Clinical Pharmacology, 1985
- Pharmacokinetics of Oral Cibenzoline in Arrhythmia PatientsClinical Pharmacokinetics, 1985
- Quantitation of cibenzoline in human plasma by gas chromatography—negative-ion chemical-ionization mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Cibenzoline for treatment of ventricular arrhythmias: A double-blind placebo-controlled studyJACC, 1984
- Single‐Dose Pharmacokinetics and Dose Proportionality of Oral CibenzolineThe Journal of Clinical Pharmacology, 1984
- Cibenzoline plasma concentration and antiarrhythmic effectClinical Pharmacology & Therapeutics, 1984
- Pharmacokinetics in man of a new antiarrhythmic drug, cibenzolineEuropean Journal of Clinical Pharmacology, 1983
- EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIABritish Journal of Pharmacology, 1982
- Physiological Availability of Vitamins. Study of Methods for Determining Availability of Vitamins in Pharmaceutical ProductsIndustrial & Engineering Chemistry Analytical Edition, 1945